Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.
2.

A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.

Price EW, Edwards KJ, Carnazza KE, Carlin SD, Zeglis BM, Adam MJ, Orvig C, Lewis JS.

Nucl Med Biol. 2016 Sep;43(9):566-76. doi: 10.1016/j.nucmedbio.2016.06.004.

PMID:
27419360
3.

In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores.

Petrik M, Zhai C, Novy Z, Urbanek L, Haas H, Decristoforo C.

Mol Imaging Biol. 2016 Jun;18(3):344-52. doi: 10.1007/s11307-015-0897-6.

4.

The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.

Zeglis BM, Lewis JS.

J Vis Exp. 2015 Feb 12;(96). doi: 10.3791/52521.

5.

Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Carroll V, Demoin DW, Hoffman TJ, Jurisson SS.

Radiochim Acta. 2012 Aug;100(8-9):653-667.

6.

What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.

Price EW, Zeglis BM, Cawthray JF, Lewis JS, Adam MJ, Orvig C.

Inorg Chem. 2014 Oct 6;53(19):10412-31. doi: 10.1021/ic501466z.

7.

Positron emission tomography image-guided drug delivery: current status and future perspectives.

Chakravarty R, Hong H, Cai W.

Mol Pharm. 2014 Nov 3;11(11):3777-97. doi: 10.1021/mp500173s. Review.

8.

Radiolabeled nanoparticles for multimodality tumor imaging.

Xing Y, Zhao J, Conti PS, Chen K.

Theranostics. 2014 Jan 24;4(3):290-306. doi: 10.7150/thno.7341. Review.

9.

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS.

Inorg Chem. 2014 Feb 17;53(4):1880-99. doi: 10.1021/ic401607z.

10.

Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.

Boros E, Rybak-Akimova E, Holland JP, Rietz T, Rotile N, Blasi F, Day H, Latifi R, Caravan P.

Mol Pharm. 2014 Feb 3;11(2):617-29. doi: 10.1021/mp400686z.

11.

H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.

Price EW, Zeglis BM, Lewis JS, Adam MJ, Orvig C.

Dalton Trans. 2014 Jan 7;43(1):119-31. doi: 10.1039/c3dt51940f.

12.

In vivo pulsed magneto-motive ultrasound imaging using high-performance magnetoactive contrast nanoagents.

Mehrmohammadi M, Shin TH, Qu M, Kruizinga P, Truby RL, Lee JH, Cheon J, Emelianov SY.

Nanoscale. 2013 Nov 21;5(22):11179-86. doi: 10.1039/c3nr03669c.

13.

H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.

Price EW, Zeglis BM, Cawthray JF, Ramogida CF, Ramos N, Lewis JS, Adam MJ, Orvig C.

J Am Chem Soc. 2013 Aug 28;135(34):12707-21. doi: 10.1021/ja4049493.

14.

Annotating MYC status with 89Zr-transferrin imaging.

Holland JP, Evans MJ, Rice SL, Wongvipat J, Sawyers CL, Lewis JS.

Nat Med. 2012 Oct;18(10):1586-91. doi: 10.1038/nm.2935.

15.

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.

Deri MA, Zeglis BM, Francesconi LC, Lewis JS.

Nucl Med Biol. 2013 Jan;40(1):3-14. doi: 10.1016/j.nucmedbio.2012.08.004. Review.

16.

A comparitive assessement of cytokine expression in human-derived cell lines exposed to alpha particles and X-rays.

Chauhan V, Howland M, Wilkins R.

ScientificWorldJournal. 2012;2012:609295. doi: 10.1100/2012/609295.

17.

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.

van Dongen GA, Poot AJ, Vugts DJ.

Tumour Biol. 2012 Jun;33(3):607-15. doi: 10.1007/s13277-012-0316-4. Review.

18.

Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.

Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J.

J Nucl Med. 2011 Oct;52(10):1608-15. doi: 10.2967/jnumed.111.092098.

19.

Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Bhattacharyya S, Dixit M.

Dalton Trans. 2011 Jun 21;40(23):6112-28. doi: 10.1039/c1dt10379b.

20.

Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.

Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J.

Mol Imaging. 2011 Jun;10(3):177-86, 1-3.

Supplemental Content

Support Center